Effects of Low Molecular Weight Heparin and Unfragmented Heparin on Induction of Osteoporosis in Rats

Summary

A comparison between the effect of low molecular weight heparin (LMWH) and unfragmented heparin (UH) on induction of osteoporosis was made in 60 rats treated with either UH (2 IU/ g b w), LMWH in 2 doses (2 Xal U/g or 0.4 Xal U/g) or placebo (saline) for 34 days. Studied variables were: bone mineral mass in femora; fragility of humera; zinc and calcium levels in serum and bone ash and albumin in plasma. A significant reduction in bone mineral mass was found in all heparin-treated rats. There was no difference between UH and LMWH in this respect. The effect was dose-dependent in LMWH-treated animals. The zinc contents in bone ash were decreased in all heparin-treated rats as compared with controls. No recognizable pattern was seen in alterations of zinc or calcium in serum. The fragility of the humera, tested as breaking strength did not differ between treatment groups and controls. In conclusion, if dosed according to similar factor Xa inhibitory activities, LMWH induces osteoporosis to the same extent as UH and in a dose-dependent manner. The zinc content in bone ash was decreased after heparin treatment, irrespective of type of heparin given.

• References

• 1 Griffith GC, Nichols G, Asher JD, Flanagan B. Heparin osteoporosis. JAMA 1965; 193: 85-8
• 2 Ringe J-D, Becker K. Osteoporoseentwicklung bei Heparinlangzeit-therapie. Med Mo Pharm 1985; 8: 80-3
• 3 Mazanec D, Grissanti JM. Drug-induced osteoporosis. Cleveland Clin J Med 1989; 56: 297-303
• 4 Matzsch T, Bergqvist D, Hedner U, Nilsson B, Østergaard P. Heparin-induced osteoporosis in rats. Thromb Haemostas 1986; 56: 293-4
• 5 Gudmundson C, Nilsson BE. Failure to produce heparin osteoporosis in rats. Acta Pharmacol Toxicol 1969; 27: 56-9
• 6 Mätzsch T, Bergqvist D, Hedner U, Nilsson B, Østergaard P. Induction of osteoporosis in rats by standard heparin and low molecular weight heparin. Thromb Haemostas 1987; 58: 36
• 7 Avioli LV. Heparin-induced osteopenia: an appraisal. Adv Exp Med Biol 1975; 52: 375-87
• 8 De Swiet M, Ward PD, Fidler J, Horsman A, Katz D, Lctsky E, Peacock M, Wise PH. Prolonged heparin therapy in pregnancy causes bone demineralization. Br J Obstct Gynaecol 1983; 90: 1129-34
• 9 Bergman B, Sjbstrom R, Wing KR. The variation with age of tissue zinc concentration in albino rats determined by atomic absorption spectrophotometry. Acta Physiol Scand 1974; 92: 440-50
• 10 Calhoun NR, Smith JC, Becker KL. The role of zinc in bone metabolism. Clin Orthop 1974; 103: 212-34
• 11 Atik OS. Zinc and senile osteoporosis. J Am Geriatr Soc 1983; 31: 790
• 12 Woodhead NE, Long WF, Williamson FB. Binding of zinc ions to heparin. Biochem J 1986; 237: 281-4
• 13 Parrish RF, Fair WR. Selective binding of zinc ions to heparin rather than to other glycosaminoglycans. Biochem J 1981; 193: 407-10
• 14 Marx G, Eldor A. The procoagulant effect of zinc on fibrin clot formation. Am J Hematol 1985; 19: 151-9
• 15 Gordon PR, O’Dell BL. Short-term zinc deficiency and hemostasis in the rat. Proc Soc Exp Biol Med 1980; 163: 240-4
• 16 Styrud J, Dahlstrom VE, Eriksson UJ. Induction of skeletal malformations in the offspring of rats fed a zinc deficient diet. Upsala J Med Sci 1986; 91: 29-36
• 17 Sakamoto S, Sakamoto M, Goldberg L, Colarusso L, Gotoh Y. Mineralization induced by β-glycerophosphate in cultures leads to a marked increase in collagenase synthesis by mouse osteogenic MC3T3-E1 cells under subsequent stimulation with heparin. Biochem Biophys Res Commun 1989; 162: 773-80
• 18 Thompson RC. Heparin osteoporosis. An experimental model using rats. J Bone Joint Surg 1973 55-A. 606-12
• 19 Petitou M. Chemical synthesis of heparin. In: Heparin Lane DA, Lindahl U. eds. Edward Arnold, Division of Hoddcr and Stoughton; London: 1989
• 20 Karnovsky MJ, Wright Jr TC, Castellot Jr JJ, Choay J, Lormeau J-C, Petitou M. Heparin, heparan sulfate, smooth muscle cells, and atherosclerosis. Ann NY Acad Sci 1989; 556: 268-81